Annual CFO
-$19.40 M
-$1.39 M-7.72%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual cash flow from operations is -$19.40 million, with the most recent change of -$1.39 million (-7.72%) on June 30, 2024.
- During the last 3 years, BNTC annual CFO has fallen by -$6.57 million (-51.21%).
- BNTC annual CFO is now -505.07% below its all-time high of $4.79 million, reached on June 30, 2019.
Performance
BNTC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$4.59 M
-$1.29 M-39.27%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly cash flow from operations is -$4.59 million, with the most recent change of -$1.29 million (-39.27%) on September 30, 2024.
- Over the past year, BNTC quarterly CFO has increased by +$779.00 thousand (+14.52%).
- BNTC quarterly CFO is now -741.47% below its all-time high of -$545.00 thousand, reached on September 30, 2019.
Performance
BNTC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$19.41 M
-$9000.00-0.05%
September 30, 2024
Summary
- As of February 7, 2025, BNTC TTM cash flow from operations is -$19.41 million, with the most recent change of -$9000.00 (-0.05%) on September 30, 2024.
- Over the past year, BNTC TTM CFO has dropped by -$1.35 million (-7.45%).
- BNTC TTM CFO is now -3461.83% below its all-time high of -$545.00 thousand, reached on September 30, 2019.
Performance
BNTC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BNTC Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.7% | +14.5% | -7.5% |
3 y3 years | -51.2% | +14.5% | -7.5% |
5 y5 years | -505.1% | +14.5% | -7.5% |
BNTC Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -51.2% | at low | -39.3% | +25.6% | -31.4% | +3.9% |
5 y | 5-year | -505.1% | at low | -496.4% | +25.6% | -436.1% | +3.9% |
alltime | all time | -505.1% | at low | -741.5% | +25.6% | -3461.8% | +3.9% |
Benitec Biopharma Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$4.59 M(+39.3%) | -$19.41 M(+0.0%) |
Jun 2024 | -$19.40 M(+7.7%) | -$3.29 M(-46.6%) | -$19.40 M(-4.0%) |
Mar 2024 | - | -$6.17 M(+15.0%) | -$20.20 M(+11.8%) |
Dec 2023 | - | -$5.37 M(+17.2%) | -$18.07 M(-2.6%) |
Sep 2023 | - | -$4.58 M(+11.8%) | -$18.54 M(+3.0%) |
Jun 2023 | -$18.01 M(+13.3%) | -$4.09 M(+1.6%) | -$18.01 M(-4.0%) |
Mar 2023 | - | -$4.03 M(-31.0%) | -$18.77 M(+3.3%) |
Dec 2022 | - | -$5.84 M(+44.4%) | -$18.16 M(+16.0%) |
Sep 2022 | - | -$4.04 M(-16.7%) | -$15.67 M(-1.5%) |
Jun 2022 | -$15.90 M | -$4.86 M(+41.9%) | -$15.90 M(-1.9%) |
Mar 2022 | - | -$3.42 M(+2.3%) | -$16.20 M(+9.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | - | -$3.34 M(-21.8%) | -$14.77 M(+0.1%) |
Sep 2021 | - | -$4.28 M(-17.0%) | -$14.75 M(+14.9%) |
Jun 2021 | -$12.83 M(+70.3%) | -$5.16 M(+159.3%) | -$12.83 M(+18.6%) |
Mar 2021 | - | -$1.99 M(-40.2%) | -$10.82 M(+12.7%) |
Dec 2020 | - | -$3.33 M(+40.9%) | -$9.60 M(+2.7%) |
Sep 2020 | - | -$2.36 M(-25.0%) | -$9.35 M(+24.1%) |
Jun 2020 | -$7.54 M(-257.3%) | -$3.15 M(+309.0%) | -$7.54 M(+71.6%) |
Mar 2020 | - | -$769.00 K(-75.0%) | -$4.39 M(+21.2%) |
Dec 2019 | - | -$3.08 M(+464.4%) | -$3.62 M(+564.4%) |
Sep 2019 | - | -$545.00 K | -$545.00 K |
Jun 2019 | $4.79 M | - | - |
FAQ
- What is Benitec Biopharma annual cash flow from operations?
- What is the all time high annual CFO for Benitec Biopharma?
- What is Benitec Biopharma annual CFO year-on-year change?
- What is Benitec Biopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Benitec Biopharma?
- What is Benitec Biopharma quarterly CFO year-on-year change?
- What is Benitec Biopharma TTM cash flow from operations?
- What is the all time high TTM CFO for Benitec Biopharma?
- What is Benitec Biopharma TTM CFO year-on-year change?
What is Benitec Biopharma annual cash flow from operations?
The current annual CFO of BNTC is -$19.40 M
What is the all time high annual CFO for Benitec Biopharma?
Benitec Biopharma all-time high annual cash flow from operations is $4.79 M
What is Benitec Biopharma annual CFO year-on-year change?
Over the past year, BNTC annual cash flow from operations has changed by -$1.39 M (-7.72%)
What is Benitec Biopharma quarterly cash flow from operations?
The current quarterly CFO of BNTC is -$4.59 M
What is the all time high quarterly CFO for Benitec Biopharma?
Benitec Biopharma all-time high quarterly cash flow from operations is -$545.00 K
What is Benitec Biopharma quarterly CFO year-on-year change?
Over the past year, BNTC quarterly cash flow from operations has changed by +$779.00 K (+14.52%)
What is Benitec Biopharma TTM cash flow from operations?
The current TTM CFO of BNTC is -$19.41 M
What is the all time high TTM CFO for Benitec Biopharma?
Benitec Biopharma all-time high TTM cash flow from operations is -$545.00 K
What is Benitec Biopharma TTM CFO year-on-year change?
Over the past year, BNTC TTM cash flow from operations has changed by -$1.35 M (-7.45%)